Search
Searching with a thematic focus on Agriculture and food, Biotechnology and GMOs, Biotechnology and GMOs governance
Showing 71-80 of 145 results
Pages
- Document
Regulating biotechnology in practice – the case of Bt cotton in India
id21 Development Research Reporting Service, 2003Regulatory policy on biotechnology advocates decision-making according to technical and scientific criteria. In practice, however, regulation emerges through a political process of negotiation between groups with diverse agendas.DocumentBiotechnology politics in Delhi’s corridors of power
id21 Development Research Reporting Service, 2003Liberalisation in India relaxed several restrictions on the activities of foreign firms that operate locally. Consequently, an increasing number of multinational agricultural biotechnology companies set up operations in India. New Delhi’s biotechnology policy is now influenced by a small number of major foreign firms and local entrepreneurs with national and global connections.DocumentTerminator technology: the economic benefits of sterile seeds
id21 Development Research Reporting Service, 2003Terminator technology – the emerging technology for inducing sterility in seeds – is potentially detrimental to both biodiversity and the livelihoods of poor farmers forced to buy fresh seed every year. Repeat seed purchase, however, provides greater scope for companies to capture returns on their research investments in plant breeding.DocumentThe discourse of the GM food debate : how language choices affect public trust
Economic and Social Research Council, UK, 2004This report examines how the UK public responded to information about GM food technology. It assesses how new technology is communicated to the public and how it is assessed by them. In 2003 when the UK government sponsored a GM National Debate, consisting of an economic review, scientific review and public consultation.DocumentAgricultural Biotechnology Research Partnerships in sub-Saharan Africa (Technology Policy Brief)
United Nations University Institute for New technologies, 2004A widely accepted mechanism for providing developing countries with access to proprietary biotechnology products and tools is the formation of partnerships between Southern and Northern research institutions and multinational private companies.DocumentModel National Biosafety Law: an introduction to the Model National Law on Biosafety
Third World Network, 1999Nations of the South are increasingly faced with the prospect of the introduction into their countries of genetically modified organisms (GMOs) and products derived from GMOs.DocumentGenetically modified crops: a decade of failure
Friends of the Earth, 2004This report discusses the impacts of genetically modified crops in relation to agricultural productivity, ten years on from when they were first commercially introduced in the United States of America.Highlights of the report include:contrary to the promises made by biotech companies, the reality of the last ten years of commercialisation shows that the safety of GM crops cannot be ensuDocumentThe new bioeconomy: industrial and environmental biotechnology in developing countries
United Nations [UN] Conference on Trade and Development, 2001This paper discusses some of the most important features of the emergence of industrial and environmental biotechnology as a growing segment of the new bioeconomy.Conclusions of the paper include:the wider adoption of these technologies will depend largely on the extent to which global economic governance provides adequate space for the emerging technologiesthe importance of a moreDocumentVoices from the south: the third world debunks corporate myths on genetically engineered crops
Institute for Food and Development Policy, 2003This paper discusses the common myths regarding genetically engineered crops, from a southern perspective.DocumentGlobalisation and the international governance of modern biotechnology: the international regulation of modern biotechnology
Eldis Document Store, 2003This paper discusses the issues surrounding the international governance and regulation of modern biotechnology.Principal conclusions of the paper include:the disciplines imposed by the relevant WTO Agreements underpin and shape the biotech regulation debate both internationally and nationallythere remains a degree of uncertainty and unpredictability regarding the scope for countriePages
